Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-08-07

Clinical Trial Update: Importance in Type 1 Diabetes Patients of an Optimized Control of Post-Prandial Glycaemia on Oxidant Stress Prevention [NA]

View source ↗

Summary

A completed clinical trial examining whether optimized control of post-prandial glycemia reduces oxidative stress in patients with Type 1 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète | Conditions: Type 1 Diabetes | NA | Status: COMPLETED